drugset / Trial / NCT02965781

Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis

NCT02965781 ↗

Phase 1/2 Completed 139 enrolled Squarex, LLC
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study evaluates the safety and efficacy of SADBE in the prevention of recurrent herpes labialis in adults. Two-thirds of the participants will receive a SADBE solution, while the other third will receive only the vehicle as a placebo control. The solutions will be administered topically to the patient's arms. The study will compare a single-arm application versus a two-arm application versus two placebo doses on the arm.

Timeline

Start
2016-12
Primary completion
2018-12-20
Completion
2018-12-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator SADBE Unknown 2 % Topical

Indications